Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy
Published in Journal 1, 2025
This paper systematically reviews recent advances in artificial intelligence (AI), with a particular focus on machine learning (ML), across the entire drug discovery pipeline.
Recommended citation: Junwei Su†, Cheng Xin†, Ao Shang, Shan Wu, Zhenzhen Xie, Ruogu Xiong, Xiaoyu Xu, Cheng Zhang, Guang Chen, Yau-Tuen Chan, Guoyi Tang*, Ning Wang, Yong Xu, Yibin Feng*(2025). Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy. Submit to Acta Pharmaceutica Sinica B.
